Industry Research Reports

Home > Reports > Medical Devices & Consumables > Polydeoxyriboneucleotide(PDRN) Filler - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Polydeoxyriboneucleotide(PDRN) Filler - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-03-10

Pages: 105 Pages

Report ld: 4615864

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Polydeoxyriboneucleotide(PDRN) Filler was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

PDRN injection’s main ingredient is Polynucleotides (PN), a component that promotes skin healing & skin glow. More importantly, PN is safe and compatible with human skin without any side effects.

North American market for Polydeoxyriboneucleotide(PDRN) Filler was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Polydeoxyriboneucleotide(PDRN) Filler was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Polydeoxyriboneucleotide(PDRN) Filler was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Polydeoxyriboneucleotide(PDRN) Filler include BioPlus Co., Ltd. (Kiara Reju), Koru Pharma(Crystal Hydro Pdrn), GANA R&D CO LTD, Sanendi, GUANGZHOU AOMA TRADING CO., LTD, Hangzhou Hafiller Medical Technology Co., Ltd., etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Polydeoxyriboneucleotide(PDRN) Filler, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Polydeoxyriboneucleotide(PDRN) Filler by region & country, by Type, and by Application.

The Polydeoxyriboneucleotide(PDRN) Filler market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polydeoxyriboneucleotide(PDRN) Filler.

MARKET SEGMENTATION

By Company

BioPlus Co., Ltd. (Kiara Reju)
Koru Pharma(Crystal Hydro Pdrn)
GANA R&D CO LTD
Sanendi
GUANGZHOU AOMA TRADING CO., LTD
Hangzhou Hafiller Medical Technology Co., Ltd.

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Gel
Solution

Segment by Application

Medical Beauty Institution
Hospital
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Polydeoxyriboneucleotide(PDRN) Filler manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Polydeoxyriboneucleotide(PDRN) Filler in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Polydeoxyriboneucleotide(PDRN) Filler in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Polydeoxyriboneucleotide(PDRN) Filler Product Introduction

1.2 Global Polydeoxyriboneucleotide(PDRN) Filler Market Size Forecast

1.2.1 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value (2020-2031)

1.2.2 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume (2020-2031)

1.2.3 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Price (2020-2031)

1.3 Polydeoxyriboneucleotide(PDRN) Filler Market Trends & Drivers

1.3.1 Polydeoxyriboneucleotide(PDRN) Filler Industry Trends

1.3.2 Polydeoxyriboneucleotide(PDRN) Filler Market Drivers & Opportunity

1.3.3 Polydeoxyriboneucleotide(PDRN) Filler Market Challenges

1.3.4 Polydeoxyriboneucleotide(PDRN) Filler Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Polydeoxyriboneucleotide(PDRN) Filler Players Revenue Ranking (2024)

2.2 Global Polydeoxyriboneucleotide(PDRN) Filler Revenue by Company (2020-2025)

2.3 Global Polydeoxyriboneucleotide(PDRN) Filler Players Sales Volume Ranking (2024)

2.4 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Company Players (2020-2025)

2.5 Global Polydeoxyriboneucleotide(PDRN) Filler Average Price by Company (2020-2025)

2.6 Key Manufacturers Polydeoxyriboneucleotide(PDRN) Filler Manufacturing Base and Headquarters

2.7 Key Manufacturers Polydeoxyriboneucleotide(PDRN) Filler Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Polydeoxyriboneucleotide(PDRN) Filler

2.9 Polydeoxyriboneucleotide(PDRN) Filler Market Competitive Analysis

2.9.1 Polydeoxyriboneucleotide(PDRN) Filler Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Polydeoxyriboneucleotide(PDRN) Filler Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polydeoxyriboneucleotide(PDRN) Filler as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Gel

3.1.2 Solution

3.2 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Type

3.2.1 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value, by Type (2020-2031)

3.2.3 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value, by Type (%) (2020-2031)

3.3 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Type

3.3.1 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume, by Type (2020-2031)

3.3.3 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume, by Type (%) (2020-2031)

3.4 Global Polydeoxyriboneucleotide(PDRN) Filler Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Medical Beauty Institution

4.1.2 Hospital

4.1.3 Others

4.2 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Application

4.2.1 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value, by Application (2020-2031)

4.2.3 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value, by Application (%) (2020-2031)

4.3 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Application

4.3.1 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume, by Application (2020-2031)

4.3.3 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume, by Application (%) (2020-2031)

4.4 Global Polydeoxyriboneucleotide(PDRN) Filler Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Region

5.1.1 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Region (2020-2025)

5.1.3 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Region (2026-2031)

5.1.4 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Region (%), (2020-2031)

5.2 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Region

5.2.1 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Region (2020-2025)

5.2.3 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Region (2026-2031)

5.2.4 Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Region (%), (2020-2031)

5.3 Global Polydeoxyriboneucleotide(PDRN) Filler Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Polydeoxyriboneucleotide(PDRN) Filler Sales Value, 2020-2031

5.4.2 North America Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Polydeoxyriboneucleotide(PDRN) Filler Sales Value, 2020-2031

5.5.2 Europe Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Polydeoxyriboneucleotide(PDRN) Filler Sales Value, 2020-2031

5.6.2 Asia Pacific Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Polydeoxyriboneucleotide(PDRN) Filler Sales Value, 2020-2031

5.7.2 South America Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Polydeoxyriboneucleotide(PDRN) Filler Sales Value, 2020-2031

5.8.2 Middle East & Africa Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Polydeoxyriboneucleotide(PDRN) Filler Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Polydeoxyriboneucleotide(PDRN) Filler Sales Value and Sales Volume

6.2.1 Key Countries/Regions Polydeoxyriboneucleotide(PDRN) Filler Sales Value, 2020-2031

6.2.2 Key Countries/Regions Polydeoxyriboneucleotide(PDRN) Filler Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Polydeoxyriboneucleotide(PDRN) Filler Sales Value, 2020-2031

6.3.2 United States Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Polydeoxyriboneucleotide(PDRN) Filler Sales Value, 2020-2031

6.4.2 Europe Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Polydeoxyriboneucleotide(PDRN) Filler Sales Value, 2020-2031

6.5.2 China Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Type (%), 2024 VS 2031

6.5.3 China Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Polydeoxyriboneucleotide(PDRN) Filler Sales Value, 2020-2031

6.6.2 Japan Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Polydeoxyriboneucleotide(PDRN) Filler Sales Value, 2020-2031

6.7.2 South Korea Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Polydeoxyriboneucleotide(PDRN) Filler Sales Value, 2020-2031

6.8.2 Southeast Asia Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Polydeoxyriboneucleotide(PDRN) Filler Sales Value, 2020-2031

6.9.2 India Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Type (%), 2024 VS 2031

6.9.3 India Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 BioPlus Co., Ltd. (Kiara Reju)

7.1.1 BioPlus Co., Ltd. (Kiara Reju) Company Information

7.1.2 BioPlus Co., Ltd. (Kiara Reju) Introduction and Business Overview

7.1.3 BioPlus Co., Ltd. (Kiara Reju) Polydeoxyriboneucleotide(PDRN) Filler Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 BioPlus Co., Ltd. (Kiara Reju) Polydeoxyriboneucleotide(PDRN) Filler Product Offerings

7.1.5 BioPlus Co., Ltd. (Kiara Reju) Recent Development

7.2 Koru Pharma(Crystal Hydro Pdrn)

7.2.1 Koru Pharma(Crystal Hydro Pdrn) Company Information

7.2.2 Koru Pharma(Crystal Hydro Pdrn) Introduction and Business Overview

7.2.3 Koru Pharma(Crystal Hydro Pdrn) Polydeoxyriboneucleotide(PDRN) Filler Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Koru Pharma(Crystal Hydro Pdrn) Polydeoxyriboneucleotide(PDRN) Filler Product Offerings

7.2.5 Koru Pharma(Crystal Hydro Pdrn) Recent Development

7.3 GANA R&D CO LTD

7.3.1 GANA R&D CO LTD Company Information

7.3.2 GANA R&D CO LTD Introduction and Business Overview

7.3.3 GANA R&D CO LTD Polydeoxyriboneucleotide(PDRN) Filler Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 GANA R&D CO LTD Polydeoxyriboneucleotide(PDRN) Filler Product Offerings

7.3.5 GANA R&D CO LTD Recent Development

7.4 Sanendi

7.4.1 Sanendi Company Information

7.4.2 Sanendi Introduction and Business Overview

7.4.3 Sanendi Polydeoxyriboneucleotide(PDRN) Filler Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Sanendi Polydeoxyriboneucleotide(PDRN) Filler Product Offerings

7.4.5 Sanendi Recent Development

7.5 GUANGZHOU AOMA TRADING CO., LTD

7.5.1 GUANGZHOU AOMA TRADING CO., LTD Company Information

7.5.2 GUANGZHOU AOMA TRADING CO., LTD Introduction and Business Overview

7.5.3 GUANGZHOU AOMA TRADING CO., LTD Polydeoxyriboneucleotide(PDRN) Filler Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 GUANGZHOU AOMA TRADING CO., LTD Polydeoxyriboneucleotide(PDRN) Filler Product Offerings

7.5.5 GUANGZHOU AOMA TRADING CO., LTD Recent Development

7.6 Hangzhou Hafiller Medical Technology Co., Ltd.

7.6.1 Hangzhou Hafiller Medical Technology Co., Ltd. Company Information

7.6.2 Hangzhou Hafiller Medical Technology Co., Ltd. Introduction and Business Overview

7.6.3 Hangzhou Hafiller Medical Technology Co., Ltd. Polydeoxyriboneucleotide(PDRN) Filler Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Hangzhou Hafiller Medical Technology Co., Ltd. Polydeoxyriboneucleotide(PDRN) Filler Product Offerings

7.6.5 Hangzhou Hafiller Medical Technology Co., Ltd. Recent Development

8 Industry Chain Analysis

8.1 Polydeoxyriboneucleotide(PDRN) Filler Industrial Chain

8.2 Polydeoxyriboneucleotide(PDRN) Filler Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Polydeoxyriboneucleotide(PDRN) Filler Sales Model

8.5.2 Sales Channel

8.5.3 Polydeoxyriboneucleotide(PDRN) Filler Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Polydeoxyriboneucleotide(PDRN) Filler Market Trends

Table 2. Polydeoxyriboneucleotide(PDRN) Filler Market Drivers & Opportunity

Table 3. Polydeoxyriboneucleotide(PDRN) Filler Market Challenges

Table 4. Polydeoxyriboneucleotide(PDRN) Filler Market Restraints

Table 5. Global Polydeoxyriboneucleotide(PDRN) Filler Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Polydeoxyriboneucleotide(PDRN) Filler Revenue Market Share by Company (2020-2025)

Table 7. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Company (2020-2025) & (K Units)

Table 8. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Polydeoxyriboneucleotide(PDRN) Filler Price by Company (2020-2025) & (US$/Unit)

Table 10. Key Manufacturers Polydeoxyriboneucleotide(PDRN) Filler Manufacturing Base and Headquarters

Table 11. Key Manufacturers Polydeoxyriboneucleotide(PDRN) Filler Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Polydeoxyriboneucleotide(PDRN) Filler

Table 13. Global Polydeoxyriboneucleotide(PDRN) Filler Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polydeoxyriboneucleotide(PDRN) Filler as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Market Share in Value by Type (2020-2025)

Table 20. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Market Share in Value by Type (2026-2031)

Table 21. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)

Table 22. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Type (2020-2025) & (K Units)

Table 23. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Type (2026-2031) & (K Units)

Table 24. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Polydeoxyriboneucleotide(PDRN) Filler Price by Type (2020-2025) & (US$/Unit)

Table 27. Global Polydeoxyriboneucleotide(PDRN) Filler Price by Type (2026-2031) & (US$/Unit)

Table 28. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Market Share in Value by Application (2020-2025)

Table 32. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Market Share in Value by Application (2026-2031)

Table 33. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)

Table 34. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Application (2020-2025) & (K Units)

Table 35. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Application (2026-2031) & (K Units)

Table 36. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Polydeoxyriboneucleotide(PDRN) Filler Price by Application (2020-2025) & (US$/Unit)

Table 39. Global Polydeoxyriboneucleotide(PDRN) Filler Price by Application (2026-2031) & (US$/Unit)

Table 40. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Region (2020-2025) & (%)

Table 44. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Region (2026-2031) & (%)

Table 45. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Region (K Units): 2020 VS 2024 VS 2031

Table 46. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Region (2020-2025) & (K Units)

Table 47. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Region (2026-2031) & (K Units)

Table 48. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Region (2020-2025) & (%)

Table 49. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Region (2026-2031) & (%)

Table 50. Global Polydeoxyriboneucleotide(PDRN) Filler Average Price by Region (2020-2025) & (US$/Unit)

Table 51. Global Polydeoxyriboneucleotide(PDRN) Filler Average Price by Region (2026-2031) & (US$/Unit)

Table 52. Key Countries/Regions Polydeoxyriboneucleotide(PDRN) Filler Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Polydeoxyriboneucleotide(PDRN) Filler Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Polydeoxyriboneucleotide(PDRN) Filler Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Polydeoxyriboneucleotide(PDRN) Filler Sales Volume, (2020-2025) & (K Units)

Table 56. Key Countries/Regions Polydeoxyriboneucleotide(PDRN) Filler Sales Volume, (2026-2031) & (K Units)

Table 57. BioPlus Co., Ltd. (Kiara Reju) Company Information

Table 58. BioPlus Co., Ltd. (Kiara Reju) Introduction and Business Overview

Table 59. BioPlus Co., Ltd. (Kiara Reju) Polydeoxyriboneucleotide(PDRN) Filler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 60. BioPlus Co., Ltd. (Kiara Reju) Polydeoxyriboneucleotide(PDRN) Filler Product Offerings

Table 61. BioPlus Co., Ltd. (Kiara Reju) Recent Development

Table 62. Koru Pharma(Crystal Hydro Pdrn) Company Information

Table 63. Koru Pharma(Crystal Hydro Pdrn) Introduction and Business Overview

Table 64. Koru Pharma(Crystal Hydro Pdrn) Polydeoxyriboneucleotide(PDRN) Filler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 65. Koru Pharma(Crystal Hydro Pdrn) Polydeoxyriboneucleotide(PDRN) Filler Product Offerings

Table 66. Koru Pharma(Crystal Hydro Pdrn) Recent Development

Table 67. GANA R&D CO LTD Company Information

Table 68. GANA R&D CO LTD Introduction and Business Overview

Table 69. GANA R&D CO LTD Polydeoxyriboneucleotide(PDRN) Filler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 70. GANA R&D CO LTD Polydeoxyriboneucleotide(PDRN) Filler Product Offerings

Table 71. GANA R&D CO LTD Recent Development

Table 72. Sanendi Company Information

Table 73. Sanendi Introduction and Business Overview

Table 74. Sanendi Polydeoxyriboneucleotide(PDRN) Filler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 75. Sanendi Polydeoxyriboneucleotide(PDRN) Filler Product Offerings

Table 76. Sanendi Recent Development

Table 77. GUANGZHOU AOMA TRADING CO., LTD Company Information

Table 78. GUANGZHOU AOMA TRADING CO., LTD Introduction and Business Overview

Table 79. GUANGZHOU AOMA TRADING CO., LTD Polydeoxyriboneucleotide(PDRN) Filler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 80. GUANGZHOU AOMA TRADING CO., LTD Polydeoxyriboneucleotide(PDRN) Filler Product Offerings

Table 81. GUANGZHOU AOMA TRADING CO., LTD Recent Development

Table 82. Hangzhou Hafiller Medical Technology Co., Ltd. Company Information

Table 83. Hangzhou Hafiller Medical Technology Co., Ltd. Introduction and Business Overview

Table 84. Hangzhou Hafiller Medical Technology Co., Ltd. Polydeoxyriboneucleotide(PDRN) Filler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 85. Hangzhou Hafiller Medical Technology Co., Ltd. Polydeoxyriboneucleotide(PDRN) Filler Product Offerings

Table 86. Hangzhou Hafiller Medical Technology Co., Ltd. Recent Development

Table 87. Key Raw Materials Lists

Table 88. Raw Materials Key Suppliers Lists

Table 89. Polydeoxyriboneucleotide(PDRN) Filler Downstream Customers

Table 90. Polydeoxyriboneucleotide(PDRN) Filler Distributors List

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Polydeoxyriboneucleotide(PDRN) Filler Product Picture

Figure 2. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume (2020-2031) & (K Units)

Figure 5. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Price (2020-2031) & (US$/Unit)

Figure 6. Polydeoxyriboneucleotide(PDRN) Filler Report Years Considered

Figure 7. Global Polydeoxyriboneucleotide(PDRN) Filler Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Polydeoxyriboneucleotide(PDRN) Filler Players Sales Volume Ranking (2024) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Polydeoxyriboneucleotide(PDRN) Filler Revenue in 2024

Figure 10. Polydeoxyriboneucleotide(PDRN) Filler Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Gel Picture

Figure 12. Solution Picture

Figure 13. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)

Figure 16. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Polydeoxyriboneucleotide(PDRN) Filler Price by Type (2020-2031) & (US$/Unit)

Figure 18. Product Picture of Medical Beauty Institution

Figure 19. Product Picture of Hospital

Figure 20. Product Picture of Others

Figure 21. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 22. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Value Market Share by Application, 2024 & 2031

Figure 23. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)

Figure 24. Global Polydeoxyriboneucleotide(PDRN) Filler Sales Volume Market Share by Application, 2024 & 2031

Figure 25. Global Polydeoxyriboneucleotide(PDRN) Filler Price by Application (2020-2031) & (US$/Unit)

Figure 26. North America Polydeoxyriboneucleotide(PDRN) Filler Sales Value (2020-2031) & (US$ Million)

Figure 27. North America Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Country (%), 2024 VS 2031

Figure 28. Europe Polydeoxyriboneucleotide(PDRN) Filler Sales Value, (2020-2031) & (US$ Million)

Figure 29. Europe Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Country (%), 2024 VS 2031

Figure 30. Asia Pacific Polydeoxyriboneucleotide(PDRN) Filler Sales Value, (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Region (%), 2024 VS 2031

Figure 32. South America Polydeoxyriboneucleotide(PDRN) Filler Sales Value, (2020-2031) & (US$ Million)

Figure 33. South America Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Country (%), 2024 VS 2031

Figure 34. Middle East & Africa Polydeoxyriboneucleotide(PDRN) Filler Sales Value, (2020-2031) & (US$ Million)

Figure 35. Middle East & Africa Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Country (%), 2024 VS 2031

Figure 36. Key Countries/Regions Polydeoxyriboneucleotide(PDRN) Filler Sales Value (%), (2020-2031)

Figure 37. Key Countries/Regions Polydeoxyriboneucleotide(PDRN) Filler Sales Volume (%), (2020-2031)

Figure 38. United States Polydeoxyriboneucleotide(PDRN) Filler Sales Value, (2020-2031) & (US$ Million)

Figure 39. United States Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Type (%), 2024 VS 2031

Figure 40. United States Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Application (%), 2024 VS 2031

Figure 41. Europe Polydeoxyriboneucleotide(PDRN) Filler Sales Value, (2020-2031) & (US$ Million)

Figure 42. Europe Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Type (%), 2024 VS 2031

Figure 43. Europe Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Application (%), 2024 VS 2031

Figure 44. China Polydeoxyriboneucleotide(PDRN) Filler Sales Value, (2020-2031) & (US$ Million)

Figure 45. China Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Type (%), 2024 VS 2031

Figure 46. China Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Application (%), 2024 VS 2031

Figure 47. Japan Polydeoxyriboneucleotide(PDRN) Filler Sales Value, (2020-2031) & (US$ Million)

Figure 48. Japan Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Type (%), 2024 VS 2031

Figure 49. Japan Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Application (%), 2024 VS 2031

Figure 50. South Korea Polydeoxyriboneucleotide(PDRN) Filler Sales Value, (2020-2031) & (US$ Million)

Figure 51. South Korea Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Type (%), 2024 VS 2031

Figure 52. South Korea Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Application (%), 2024 VS 2031

Figure 53. Southeast Asia Polydeoxyriboneucleotide(PDRN) Filler Sales Value, (2020-2031) & (US$ Million)

Figure 54. Southeast Asia Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Type (%), 2024 VS 2031

Figure 55. Southeast Asia Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Application (%), 2024 VS 2031

Figure 56. India Polydeoxyriboneucleotide(PDRN) Filler Sales Value, (2020-2031) & (US$ Million)

Figure 57. India Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Type (%), 2024 VS 2031

Figure 58. India Polydeoxyriboneucleotide(PDRN) Filler Sales Value by Application (%), 2024 VS 2031

Figure 59. Polydeoxyriboneucleotide(PDRN) Filler Industrial Chain

Figure 60. Polydeoxyriboneucleotide(PDRN) Filler Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Polydeoxyriboneucleotide(PDRN) Filler market? zhanKai

The top companies in the global Polydeoxyriboneucleotide(PDRN) Filler market are BioPlus Co., Ltd. (Kiara Reju)、Koru Pharma(Crystal Hydro Pdrn)、GANA R&D CO LTD.

Related Reports

Global Polydeoxyriboneucleotide(PDRN) Filler Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Polydeoxyriboneucleotide(PDRN) Filler market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 79
USD 4250.00
(Single User License)
Global Polydeoxyriboneucleotide(PDRN) Filler Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Polydeoxyriboneucleotide(PDRN) Filler market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 145
USD 4900.00
(Single User License)
Polydeoxyriboneucleotide(PDRN) Filler- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Polydeoxyriboneucleotide(PDRN) Filler was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 91
USD 3950.00
(Single User License)
Global Polydeoxyriboneucleotide(PDRN) Filler Market Research Report 2026
The global Polydeoxyriboneucleotide(PDRN) Filler market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 115
USD 2900.00
(Single User License)
Global Polydeoxyriboneucleotide(PDRN) Filler Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Polydeoxyriboneucleotide(PDRN) Filler market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 131
USD 4900.00
(Single User License)
Global Polydeoxyriboneucleotide(PDRN) Filler Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Polydeoxyriboneucleotide(PDRN) Filler market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 77
USD 4250.00
(Single User License)
Global Polydeoxyriboneucleotide(PDRN) Filler Market Research Report 2025
The global market for Polydeoxyriboneucleotide(PDRN) Filler was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 81
USD 2900.00
(Single User License)
Global and United States Polydeoxyriboneucleotide(PDRN) Filler Market Report & Forecast 2024-2030
PDRN injection’s main ingredient is Polynucleotides (PN), a component that promotes skin healing & skin glow. More importantly, PN is safe and compatible with human skin without any side effects.
Published Date: 2024-06-27
Pages: 109
USD 4350.00
(Single User License)
Global Polydeoxyriboneucleotide(PDRN) Filler Market Research Report 2024
PDRN injection’s main ingredient is Polynucleotides (PN), a component that promotes skin healing & skin glow. More importantly, PN is safe and compatible with human skin without any side effects.
Published Date: 2024-06-27
Pages: 78
USD 2900.00
(Single User License)
Global Polydeoxyriboneucleotide(PDRN) Filler Market Insights, Forecast to 2030
PDRN injection’s main ingredient is Polynucleotides (PN), a component that promotes skin healing & skin glow. More importantly, PN is safe and compatible with human skin without any side effects.
Published Date: 2024-06-27
Pages: 126
USD 4900.00
(Single User License)

Global Polydeoxyriboneucleotide(PDRN) Filler Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Polydeoxyriboneucleotide(PDRN) Filler market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 79
USD 4250.00 (Single User License)
Global Polydeoxyriboneucleotide(PDRN) Filler Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Polydeoxyriboneucleotide(PDRN) Filler market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 145
USD 4900.00 (Single User License)
Polydeoxyriboneucleotide(PDRN) Filler- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Polydeoxyriboneucleotide(PDRN) Filler was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 91
USD 3950.00 (Single User License)
Global Polydeoxyriboneucleotide(PDRN) Filler Market Research Report 2026
The global Polydeoxyriboneucleotide(PDRN) Filler market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 115
USD 2900.00 (Single User License)
Global Polydeoxyriboneucleotide(PDRN) Filler Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Polydeoxyriboneucleotide(PDRN) Filler market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 131
USD 4900.00 (Single User License)
Global Polydeoxyriboneucleotide(PDRN) Filler Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Polydeoxyriboneucleotide(PDRN) Filler market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 77
USD 4250.00 (Single User License)
Global Polydeoxyriboneucleotide(PDRN) Filler Market Research Report 2025
The global market for Polydeoxyriboneucleotide(PDRN) Filler was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 81
USD 2900.00 (Single User License)
Global and United States Polydeoxyriboneucleotide(PDRN) Filler Market Report & Forecast 2024-2030
PDRN injection’s main ingredient is Polynucleotides (PN), a component that promotes skin healing & skin glow. More importantly, PN is safe and compatible with human skin without any side effects.
Published: 2024-06-27
Pages: 109
USD 4350.00 (Single User License)
Global Polydeoxyriboneucleotide(PDRN) Filler Market Research Report 2024
PDRN injection’s main ingredient is Polynucleotides (PN), a component that promotes skin healing & skin glow. More importantly, PN is safe and compatible with human skin without any side effects.
Published: 2024-06-27
Pages: 78
USD 2900.00 (Single User License)
Global Polydeoxyriboneucleotide(PDRN) Filler Market Insights, Forecast to 2030
PDRN injection’s main ingredient is Polynucleotides (PN), a component that promotes skin healing & skin glow. More importantly, PN is safe and compatible with human skin without any side effects.
Published: 2024-06-27
Pages: 126
USD 4900.00 (Single User License)